Literature DB >> 690183

Pancreatic and gastric somatostatin release in response to intragastric and intraduodenal nutrients and HCl in the dog.

V Schusdziarra, V Harris, J M Conlon, A Arimura, R Unger.   

Abstract

The effects of the instillation of glucose, fat, casein hydrolysate, and HCl into the gastrointestinal tract upon plasma levels of somatostatin-like immunoreactivity (SLI) in the venous effluent of the pancreas, fundus and antrum of the stomach, and in the inferior vena cava (IVC) were determined in normal laparotomized dogs. Fasting SLI levels in the effluent plasma from these sites were significantly greater than IVC levels. The intragastric administration of glucose elicited a prompt and significant rise in SLI levels in pancreatic, fundic and antral venous plasma, and in IVC plasma; intraduodenal glucose elicited smaller increments. After intragastric fat, a smaller, more gradual increase in the pancreatic and fundic effluents was observed, whereas the rise in antral SLI was minute, and IVC SLI did not rise significantly. Intraduodenal fat elicited a prompt increase in the pancreatic and antral vein SLI levels, and a small but significant increase in fundic and IVC plasma which suggests faster release of enteric factors that influence SLI secretion in the pancreas and antrum. Intragastric casein hydrolysate elicited a prompt increase in SLI in both the pancreatic and fundic veins, the latter being marked, but the antral SLI response was small; IVC SLI rose significantly within 15 min. Intragastric HCl provoked a prompt and marked rise in pancreaticoduodenal and antral vein SLI but no increase in fundic vein SLI; IVC SLI levels rose significantly within 20 min. Intraduodenal HCl elicited an even more prompt and marked pancreatic SLI response, and SLI rose significantly in both the fundic and antral venous effluents; IVC SLI also rose more promptly. In dogs with a gastric fistula that prevented intraduodenal entry of HCl, intragastric HCl elicited only a very small and transient rise in pancreaticoduodenal vein SLI, markedly stimulated the antral SLI response, but completely suppressed fundic venous SLI levels. The results indicate that all three nutrients stimulate SLI release from the pancreas and stomach. The greater SLI response to intragastric, as opposed to intraduodenal, glucose suggests that unidentified local factors are of importance. The responses to the intraduodenal instillation of HCl and fat suggest a role of enteric hormones in the release of SLI from the pancreas and fundus and antrum of the stomach. Additionally, there is evidence of direct effects of HCl upon gastric SLI release.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 690183      PMCID: PMC371793          DOI: 10.1172/JCI109154

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  31 in total

1.  Immunoassay of endogenous plasma insulin in man.

Authors:  R S YALOW; S A BERSON
Journal:  J Clin Invest       Date:  1960-07       Impact factor: 14.808

2.  A radioimmunoassay for growth hormone release-inhibiting hormone: method and quantitative tissue distribution.

Authors:  S Kronheim; M Berelowitz; B L Pimstone
Journal:  Clin Endocrinol (Oxf)       Date:  1976-11       Impact factor: 3.478

3.  The effects of gastrin, gastric inhibitory polypeptide, secretin, and the octapeptide of cholecystokinin upon immunoreactive somatostatin release by the perfused canine pancreas.

Authors:  E Ipp; R E Dobbs; V Harris; A Arimura; W Vale; R H Unger
Journal:  J Clin Invest       Date:  1977-11       Impact factor: 14.808

4.  Immunoreactive somatostatin levels in plasma of normal and alloxan diabetic dogs.

Authors:  V Schusdziarra; R E Dobbs; V Harris; R H Unger
Journal:  FEBS Lett       Date:  1977-09-01       Impact factor: 4.124

5.  Hypothesis: physiologic role of pancreatic somatostatin and the contribution of D-cell disorders to diabetes mellitus.

Authors:  R H Unger; E Ipp; V Schusdziarra; L Orci
Journal:  Life Sci       Date:  1977-06-15       Impact factor: 5.037

Review 6.  The newer gut hormones. Cellular sources, physiology, pathology, and clinical aspects.

Authors:  A G Pearse; J M Polak; S R Bloom
Journal:  Gastroenterology       Date:  1977-04       Impact factor: 22.682

7.  Growth-hormone release-inhibiting hormone in gastrointestinal and pancreatic D cells.

Authors:  J M Polak; A G Pearse; L Grimelius; S R Bloom
Journal:  Lancet       Date:  1975-05-31       Impact factor: 79.321

8.  Inhibition by somatostatin of glucagon-induced glucose release from the isolated perfused rat liver.

Authors:  H Sacks; K Waligora; J Matthews; B Pimstone
Journal:  Endocrinology       Date:  1977-12       Impact factor: 4.736

9.  Plasma secretin concentration in man: effect of intraduodenal glucose, fat, amino acids, ethanol, HCl, or ingestion of a meal.

Authors:  J Fahrenkrug; O B Schaffalitzky de Muckadell
Journal:  Eur J Clin Invest       Date:  1977-06       Impact factor: 4.686

10.  Release of immunoreactive somatostatin from the pancreas in response to glucose, amino acids, pancreozymin-cholecystokinin, and tolbutamide.

Authors:  E Ipp; R E Dobbs; A Arimura; W Vale; V Harris; R H Unger
Journal:  J Clin Invest       Date:  1977-09       Impact factor: 14.808

View more
  36 in total

1.  Effects of pirenzepine on omeprazole-induced gastrin gene expression in rat antral tissues.

Authors:  A Tari; M Hamada; T Kamiyasu; Y Fukino; M Sumii; K Sumii; G Kajiyama
Journal:  Dig Dis Sci       Date:  1996-06       Impact factor: 3.199

2.  Gastric luminal somatostatin secretion of normals and patients with pernicious anemia and with Zollinger-Ellison syndrome.

Authors:  A Ertan; A Ozden; E Golodner; H Degertekin; A Arimura
Journal:  Dig Dis Sci       Date:  1988-12       Impact factor: 3.199

3.  Reciprocal regulation of antral gastrin and somatostatin gene expression by omeprazole-induced achlorhydria.

Authors:  S J Brand; D Stone
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

4.  Intestinal control of gastric function in the calf: the relationship of neural and endocrine factors.

Authors:  F R Bell; A R Green; J A Wass; D E Webber
Journal:  J Physiol       Date:  1981-12       Impact factor: 5.182

5.  Release of somatostatin-like immunoreactivity from the perfused canine thyroid. Selective stimulatory effect of calcium ions.

Authors:  P Laurberg; H Orskov
Journal:  J Clin Invest       Date:  1981-05       Impact factor: 14.808

6.  Plasma somatostatin-like immunoreactivity during the interdigestive period in the dog.

Authors:  I Aizawa; Z Itoh; V Harris; R H Unger
Journal:  J Clin Invest       Date:  1981-07       Impact factor: 14.808

7.  Properties of endogenous somatostatin-like immunoreactivity and synthetic somatostatin in dog plasma.

Authors:  J M Conlon; C B Srikant; E Ipp; V Schusdziarra; W Vale; R H Unger
Journal:  J Clin Invest       Date:  1978-12       Impact factor: 14.808

8.  Somatostatin in gastric juice in normal subjects and patients with duodenal ulcer.

Authors:  K Sumii; M Sumioka; M Yoshihara; A Tari; K Haruma; G Kajiyama
Journal:  Dig Dis Sci       Date:  1992-07       Impact factor: 3.199

9.  Contribution of the pancreas to circulating somatostatin-like immunoreactivity in the normal dog.

Authors:  G J Taborsky; J W Ensinck
Journal:  J Clin Invest       Date:  1984-01       Impact factor: 14.808

10.  Suppression of somatostatin release by duodenogastric reflux in dogs.

Authors:  W E Thomas; J Ardill; K D Buchanan
Journal:  Gut       Date:  1984-11       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.